EMERGING NOVEL NANOPHARMACEUTICALS FOR DRUG DELIVERY
DOI:
https://doi.org/10.22159/ajpcr.2018.v11i7.25149Keywords:
Nanopharmaceuticals, Nanowafers, Nanosponges, Nanofibres, Carbon nanotubesAbstract
Nanotechnology is an area of growing public interest. Employing nanotechnology in the field of drug delivery has led to the advent of nanopharmaceuticals. Nanopharmaceuticals are bound to surmount various obstacles that the field of pharmacy is currently facing by offering various advantages thereby, a promising potential to formulate advanced medicines with fewer adverse effects. Extensive research is in place, thus instigating the development of novel drug delivery systems, such as carbon nanotubes, nanosponges, nano wafers, and nanofibers, to name a few. Since their inception, these nanopharmaceuticals have advanced significantly regarding their preparation strategy and scope of applications. This article aims to review the merits, limitations, and scope of these aforementioned delivery systems.
Downloads
References
Gaur A, Bhatia AL. Nanopharmaceuticals: An overview. Asian J Exp Sci 2008;22:51-62.
Ali J. Nanopharmaceutics. Int J Pharm Invest 2011;1:61.
Davis ME. Nanoparticles for systemic medicines and imaging agents. Nanotech L Bus 2006;3:255.
Chavda H. Nanopharmaceuticals: The pharmaceuticals of the present era. Ely J Pharm Res 2016;1:106e.
Panda BP, Varaprasad R, Priyanka K, Swain RP. Current trends in design and development of nanopharmaceutical dosage forms. Bioequiv Bioavailab Int J 2017;1:104.
Koopaei NN, Abdollahi M. Erratum to: Opportunities and obstacles to the development of nanopharmaceuticals for human use. Daru 2016;24:25.
Horstkotte E, Odoerfer KI. Towards improved therapies using nanopharmaceuticals: Recent patents on pharmaceutical nanoformulations. Recent Pat Food Nutr Agric 2012;4:220-44.
Osmani RM, Kulkarni AS, Aloorkar NH, Bhosale RR, Ghodake PP, Harkare BR. Carbon nanotubes: An impending carter in therapeutics. Int J Pharm Clin Res 2014;6:84-96.
Tobias G, Mendoza E, Ballesteros B. Functionalization of carbon nanotubes. In: Encyclopedia of Nanotechnology. Netherlands: Springer; 2012. p. 911-9.
Lekawa-Raus A, Patmore J, Kurzepa L, Bulmer J, Koziol K. Electrical properties of carbon nanotube based fibers and their future use in electrical wiring. Adv Funct Mater 2014;24:3661-82.
Kostarelos K, Bianco A, Prato M. Promises, facts and challenges for carbon nanotubes in imaging and therapeutics. Nat Nanotechnol 2009;4:627-33.
Firme CP 3rd, Bandaru PR. Toxicity issues in the application of carbon nanotubes to biological systems. Nanomedicine 2010;6:245-56.
Luleå University of Technology. Researcher Warns of Health Risks with Carbon Nanotubes. Science Daily. Sweden: Science Daily; 2011
Rafique MM, Iqbal J. Production of carbon nanotubes by different routes-a review. J Encapsulation Adsorpt Sci 2011;1:29.
Zhang W, Zhang Z, Zhang Y. The application of carbon nanotubes in target drug delivery systems for cancer therapies. Nanoscale Res Lett 2011;6:555.
Usui Y, Haniu H, Tsuruoka S, Saito N. Carbon nanotubes innovate on medical technology. Med Chem 2012;2:1-6.
Lay CL, Liu J, Liu Y. Functionalized carbon nanotubes for anticancer drug delivery. Expert Rev Med Devices 2011;8:561-6.
Pantarotto D, Singh R, McCarthy D, Erhardt M, Briand JP, Prato M, et al. Functionalized carbon nanotubes for plasmid DNA gene delivery. Angew Chem 2004;116:5354-8.
Bekyarova E, Ni Y, Malarkey EB, Montana V, McWilliams JL, Haddon RC, et al. Applications of carbon nanotubes in biotechnology and biomedicine. J Biomed Nanotechnol 2005;1:3-17.
Dey PR, Das NI. Carbon nanotubes: It’s role in modern health care. Int J Pharm Pharm Sci 2013;5:9-13.
Digge MS, Moon RS, Gattani SG. Applications of carbon nanotubes in drug delivery: A review. Int J PharmTech Res 2012;4:839-47.
Liao H, Paratala B, Sitharaman B, Wang Y. Applications of carbon nanotubes in biomedical studies. Methods Mol Biol 2011;726:223-41.
Wu W, Wieckowski S, Pastorin G, Benincasa M, Klumpp C, Briand JP,et al. Targeted delivery of amphotericin B to cells by using functionalized carbon nanotubes. Angew Chem Int Ed Engl 2005;44:6358-62.
Hilder TA, Hill JM. Modelling the encapsulation of the anticancer drug cisplatin into carbon nanotubes. Nanotechnology 2007;18:275704.
Vashist SK, Zheng D, Pastorin G, Al-Rubeaan K, Luong JH, Sheu FS. Delivery of drugs and biomolecules using carbon nanotubes. Carbon 2011;49:4077-97.
Chen Z, Pierre D, He H, Tan S, Pham-Huy C, Hong H, et al. Adsorption behavior of epirubicin hydrochloride on carboxylated carbon nanotubes. Int J Pharm 2011;405:153-61.
Wu L, Man C, Wang H, Lu X, Ma Q, Cai Y, et al. PEGylated multi-walled carbon nanotubes for encapsulation and sustained release of oxaliplatin. Pharm Res 2013;30:412.
Sobhani Z, Dinarvand R, Atyabi F, Ghahremani M, Adeli M. Increased paclitaxel cytotoxicity against cancer cell lines using a novel functionalized carbon nanotube. Int J Nanomedicine 2011;6:705-19.
Selvamuthukumar S, Anandam S, Krishnamoorthy K, Rajappan M. Nanosponges: A novel class of drug delivery system-review. J Pharm Pharm Sci 2012;15:103-11.
Patel G, Patel JK. Use of a microsponge in drug delivery systems. Pharm Proc 2008;158:1.
Khopade AJ, Jain S, Jain NK. The microsponge. East Pharm 1996;39:49-53.
Jain N, Devi VK, Dang E. Uday bhosale: Micro sponges: A novel drug delivery system. APTI Bulletin 2013;15.
Vishwakarma A, Nikam P, Mogal R, Talele S. Review on nanosponges: A benefication for novel drug delivery. Int J PharmTech Res 2014;6:11-20.
Shivani S, Poladi KK. Nanosponges-novel emerging drug delivery system: A review. Int J Pharm Sci Res 2015;6:529.
Jilsha G, Viswanad V. Nanosponges: A novel approach of drug delivery system. Int J Pharm Sci Rev Res 2013;19:119-23.
Kaur G, Aggarwal G, Harikumar SL. Nanosponge: New colloidal drug delivery system for topical delivery. Indo Glob J Pharm Sci 2015;5:53-7.
Karalis V, Macheras P, Van Peer A, Shah VP. Bioavailability and bioequivalence: Focus on physiological factors and variability. Pharm Res 2008;25:1956-62.
Sharma R, Walker RB, Pathak K. Evaluation of the kinetics and mechanism of drug release from econazole nitrate nanosponge loaded carbapol hydrogel. Indian J Pharm Educ Res 2011;45:25-31.
Setijadi E, Tao L, Liu J, Jia Z, Boyer C, Davis TP. Biodegradable star polymers functionalized with β-cyclodextrin inclusion complexes. Biomacromolecules 2009;10:2699-707.
Trotta F, Cavalli R, Tumiatti W, Zerbinati O, Roggero C, Vallero R, et al. Ultrasound-Assisted Synthesis of Cyclodextrin-Based Nanosponges. United States Patent Application US 11/630,403. 2008 Sep 4.
Patel EK, Oswal RJ. Nanosponge and micro sponges: A novel drug delivery system. Int J Res Pharm Chem 2012;2:237-44.
Lala R, Thorat A, Gargote C. Current trends in β-cyclodextrin based drug delivery systems. Int J Res Ayurveda Pharm 2011;2:1520-6.
Alongi J, Poskovic M, Frache A, Trotta F. Role of β-cyclodextrin nanosponges in polypropylene photooxidation. Carbohydr Polym 2011;86:127-35.
Cavalli R, Akhter AK, Bisazza A, Giustetto P, Trotta F, Vavia P, et al. Nanosponge formulations as oxygen delivery systems. Int J Pharm 2010;402:254-7.
Marcano DC, Shin CS, Lee B, Isenhart LC, Liu X, Li F, et al. Synergistic cysteamine delivery nanowafer as an efficacious treatment modality for corneal cystinosis. Mol Pharm 2016;13:3468-77.
Singh D, Soni GC, Prajapati SK. Recent advances in nanosponges as drug delivery system: A review. Eur J Pharm Med Res 2016;3:364-71.
Shankar S, Linda P, Loredana S, Francesco T, Pradeep V, Dino A, et al. Cyclodextrin-based nanosponges encapsulating camptothecin: Physicochemical characterization stability and cytotoxicity. Eur J Pharm Biopharm 2013;74:193-201.
Gigliotti CL, Ferrara B, Occhipinti S, Boggio E, Barrera G, Pizzimenti S, et al. Enhanced cytotoxic effect of camptothecin nanosponges in anaplastic thyroid cancer cells in vitro and in vivo on orthotopic xenograft tumors. Drug Deliv 2017;24:670-80.
Dubey P, Sharma HK, Shah S, Tyagi CK, Chandekar AR, Jadon RS. Formulations and evaluation of cyclodextrin complexed ceadroxil loaded nanosponges. Int J Drug Delivery 2017;9:84-100.
Gangadharappa HV, Prasad SM, Singh RP. Formulation, in vitro and in vivo evaluation of celecoxib nanosponge hydrogels for topical application. J Drug Delivery Sci Technol 2017;41:488-501.
Swaminathan S, Vavia PR, Trotta F, Cavalli R. Nanosponges encapsulating dexamethasone for ocular delivery: Formulation design, physicochemical characterization, safety and corneal permeability assessment. J Biomed Nanotechnol 2013;9:998-1007.
Swaminathan S, Cavalli R, Trotta F. Cyclodextrin-based nanosponges: A versatile platform for cancer nanotherapeutics development. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2016;8:579-601.
Rao MR, Bhingole RC. Nanosponge-based pediatric-controlled release dry suspension of gabapentin for reconstitution. Drug Dev Ind Pharm 2015;41:2029-36.
Choi WI, Sahu A, Vilos C, Kamaly N, Jo SM, Lee JH, et al. Bioinspired heparin nanosponge prepared by photo-crosslinking for controlled release of growth factors. Sci Rep 2017;7:14351.
Swaminathan S, Vavia PR, Trotta F, Torne S. Formulation of betacyclodextrin based nanosponges of itraconazole. J Inclusion Phenom Macrocyclic Chem 2007;57:89-94.
Shringirishi M, Mahor A, Gupta R, Prajapati SK, Bansal K, Kesharwani P. Fabrication and characterization of nifedipine loaded β-cyclodextrin nanosponges: An in vitro and in vivo evaluation. J Drug Delivery Sci Technol 2017;41:344-50.
Ansari KA, Vavia PR, Trotta F, Cavalli R. Cyclodextrin-based nanosponges for delivery of resveratrol: In vitro characterisation, stability, cytotoxicity and permeation study. AAPS PharmSciTech 2011;12:279-86.
Zainuddin R, Zaheer Z, Sangshetti JN, Momin M. Enhancement of oral bioavailability of anti-HIV drug rilpivirine HCl through nanosponge formulation. Drug Dev Ind Pharm 2017;43:2076-84.
Lockhart JN, Stevens DM, Beezer DB, Kravitz A, Harth E. Dual drug delivery of tamoxifen and quercetin: Regulated metabolism for anticancer treatment with nanosponges. J Controlled Release 2015;220:751-7.
Lu Z, Bu C, Hu W, Zhang H, Liu M, Lu M, et al. Preparation and in vitro and in vivo evaluation of quercetin-loaded mixed micelles for oral delivery. Biosci Biotechnol Biochem 2018;82:238-46.
Yuan X, Marcano DC, Shin CS, Hua X, Isenhart LC, Pflugfelder SC, et al. Ocular drug delivery nanowafer with enhanced therapeutic efficacy. ACS Nano 2015;9:1749-58.
Kim J, Schlesinger EB, Desai TA. Nanostructured materials for ocular delivery: Nanodesign for enhanced bioadhesion, transepithelial permeability and sustained delivery. Ther Deliv 2015;6:1365-76.
Bian F, Shin CS, Wang C, Pflugfelder SC, Acharya G, De Paiva CS, et al. Dexamethasone drug eluting nanowafers control inflammation in alkali-burned corneas associated with dry eye. Invest Ophthalmol Vis Sci 2016;57:3222-30.
Pflugfelder SC. Broadly Applicable Nanowafer Drug Delivery System for Treating Eye Injuries. Houston, TX: Baylor College of Medicine Houston United States; 2017.
Patel A, Cholkar K, Agrahari V, Mitra AK. Ocular drug delivery systems: An overview. World J Pharmacol 2013;2:47-64.
Sikandar MK, Sharma PK, Visht S. Ocular drug delivery system: An overview. Int J Pharm Sci Res 2011;2:1168.
Wang J, Williamson GS, Lancina II, Michael G, Yang H. Mildly cross-linked Dendrimer hydrogel prepared via aza-michael addition reaction for topical brimonidine delivery. J Biomed Nanotechnol 2017;13:1089-96.
Qin G, Zhu Z, Li S, McDermott AM, Cai C. Development of ciprofloxacin-loaded contact lenses using fluorous chemistry. Biomaterials 2017;124:55-64.
Lyseng-Williamson KA. Cystadrops®(cysteamine hydrochloride 0.55% viscous eye-drops solution) in treating corneal cystine crystal deposits in patients with cystinosis: A profile of its use. Drugs Ther Perspect 2017;33:195-201.
Acharya G. The Dexamethasone Nanowafer: A Novel Method of Drug Delivery for Dry Eye Disease. Houston, Texas, USA: Baylor College of Medicine; 2015.
Richa V. A Novel Particle-Based in situ Gelling System for Delivering Hydrogen Sulfide at a Sustained Rate for Potential Application in Glaucoma and Retinal Neurodegeneration. PhD Diss., Creighton University; 2017.
Vasita R, Katti DS. Nanofibers and their applications in tissue engineering. Int J Nanomed 2006;1:15.
Khajavi R, Abbasipour M, Bahador A. Electrospun biodegradable nanofibers scaffolds for bone tissue engineering. J Appl Polym Sci 2016;133 :2-19.
Li D, Xia Y. Electrospinning of nanofibers: Reinventing the wheel? Adv Mater 2004;16:1151-70.
Yu DG, Zhu LM, White K, Branford-White C. Electrospun nanofiber-based drug delivery systems. Health 2009;1:67.
Ramakrishna S. An Introduction to Electrospinning and Nanofibers. New Jersey, London, Singapore: World Scientific; 2005.
Bhardwaj N, Kundu SC. Electrospinning: A fascinating fiber fabrication technique. Biotechnol Adv 2010;28:325-47.
KarakaÅŸ H. Electrospinning of Nanofibers and There Applications. Istanbul Technical University, Textile Technologies and Design Faculty; 2015.
Kim SE, Heo DN, Lee JB, Kim JR, Park SH, Jeon SH, et al. Electrospun gelatin/polyurethane blended nanofibers for wound healing. Biomed Mater 2009;4:044106.
Zhang Y, Lim CT, Ramakrishna S, Huang ZM. Recent development of polymer nanofibers for biomedical and biotechnological applications. J Mater Sci Mater Med 2005;16:933-46.
Xie Z, Paras CB, Weng H, Punnakitikashem P, Su LC, Vu K, et al. Dual growth factor releasing multi-functional nanofibers for wound healing. Acta Biomater 2013;9:9351-9.
Yoo HS, Kim TG, Park TG. Surface-functionalized electrospun nanofibers for tissue engineering and drug delivery. Adv Drug Deliv Rev 2009;61:1033-42.
Bagul R, Mahajan V, Dhake A. New approaches in nanoparticulate drug delivery system: A review. Int J Curr Pharm Res 2012;4:29-38.
Abrigo M, McArthur SL, Kingshott P. Electrospun nanofibers as dressings for chronic wound care: Advances, challenges, and future prospects. Macromol Biosci 2014;14:772-92.
Bangale MS, Sachin M, Gattani SG, Sakarkar DM. Recent nanotechnological aspects in cosmetics and dermatological preparations. Int J Pharm Pharm Sci 2012;4:88-97.
Görbitz CH. Nanotube formation by hydrophobic dipeptides. Chemistry 2001;7:5153-9.
Taepaiboon P, Rungsardthong U, Supaphol P. Vitamin-loaded electrospun cellulose acetate nanofiber mats as transdermal and dermal therapeutic agents of vitamin A acid and vitamin E. Eur J Pharm Biopharm 2007;67:387-97.
Arduino C, Eandi M. Kinetics of thyroxine epicutaneous absorption. Pharmacol Res 1989;21:109-10.
Johal HS, Garg T, Rath G, Goyal AK. Advanced topical drug delivery system for the management of vaginal candidiasis. Drug Deliv 2016;23:550-63.
Kashyap N, Viswanad B, Sharma G, Bhardwaj V, Ramarao P, Ravi Kumar MN, et al. Design and evaluation of biodegradable, biosensitive in situ gelling system for pulsatile delivery of insulin. Biomaterials 2007;28:2051-60.
Gilchrist SE, Lange D, Letchford K, Bach H, Fazli L, Burt HM. Fusidic acid and rifampicin co-loaded PLGA nanofibers for the prevention of orthopedic implant associated infections. J Controlled Release 2013;170:64-73.
Torres-Giner S, Martinez-Abad A, Gimeno-Alcañiz JV, Ocio MJ, Lagaron JM. Controlled delivery of gentamicin antibiotic from bioactive electrospun polylactide-based ultrathin fibers. Adv Eng Mater 2012;14:B112-22.
Westphal M, Hilt DC, Bortey E, Delavault P, Olivares R, Warnke PC, et al. A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma. Neuro Oncol 2003;5:79-88.
Steiniger SC, Kreuter J, Khalansky AS, Skidan IN, Bobruskin AI, Smirnova ZS, et al. Chemotherapy of glioblastoma in rats using doxorubicin-loaded nanoparticles. Int J Cancer 2004;109:759-67.
Zeng J, Xu X, Chen X, Liang Q, Bian X, Yang L, et al. Biodegradable electrospun fibers for drug delivery. J Controlled Release 2003;92:227-31.
Kenawy el-R, Bowlin GL, Mansfield K, Layman J, Simpson DG, Sanders EH, et al. Release of tetracycline hydrochloride from electrospun poly(ethylene-co-vinylacetate), poly(lactic acid), and a blend. J Control Release 2002;81:57-64.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
